Fig. 6.
Fig. 6. Assessment of the T-cell potential of CD34+CD41−, CD34+CD41+CD42−, and CD34−CD41+CD42− cells from cord blood–cultured CD34+ cells. / (A) Cells extracted from each thymic lobe were labeled by R-PE anti–human CD4 and FITC anti–human CD8 mAbs and analyzed by flow cytometry after 30 days of culture. A: CD34−CD41+CD42− cells. B/C/D: CD34+CD41− cells. E/F/G: CD34+CD41+CD42− cells. A: 20 000 cells per lobe. B/E: 5000 cells per lobe. C/F: 1000 cells per lobe. D/G: 200 cells per lobe. (B) Proportion of negative lobes in the FTOC assays. Limiting dilution analysis of the results shown in Figure 6 are illustrated. They are derived from the analysis of 6 NOD-SCID lobes by cell concentration after 30 days of organotypic cultures. Cells recovered from the thymic lobes were analyzed by flow cytometry after labeling with anti-CD4 and CD8 antibodies. The concentration of cells ranged from 5000 to 200 cells with 6 thymic lobes by cell concentration.

Assessment of the T-cell potential of CD34+CD41, CD34+CD41+CD42, and CD34CD41+CD42 cells from cord blood–cultured CD34+ cells.

(A) Cells extracted from each thymic lobe were labeled by R-PE anti–human CD4 and FITC anti–human CD8 mAbs and analyzed by flow cytometry after 30 days of culture. A: CD34CD41+CD42 cells. B/C/D: CD34+CD41 cells. E/F/G: CD34+CD41+CD42 cells. A: 20 000 cells per lobe. B/E: 5000 cells per lobe. C/F: 1000 cells per lobe. D/G: 200 cells per lobe. (B) Proportion of negative lobes in the FTOC assays. Limiting dilution analysis of the results shown in Figure 6 are illustrated. They are derived from the analysis of 6 NOD-SCID lobes by cell concentration after 30 days of organotypic cultures. Cells recovered from the thymic lobes were analyzed by flow cytometry after labeling with anti-CD4 and CD8 antibodies. The concentration of cells ranged from 5000 to 200 cells with 6 thymic lobes by cell concentration.

Close Modal

or Create an Account

Close Modal
Close Modal